Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Waldenstrom Macroglobulinemia
×
ibrutinib
×
Clear all
Filters
3
NCT03053440
2024-10-26
ASPEN
BeiGene
Phase 3
Completed
201 enrolled
19 charts
1 FDA